Editorial to "Journey into the immunological properties of engineered nanomaterials: There and back again"

Adv Drug Deliv Rev. 2022 Feb:181:114100. doi: 10.1016/j.addr.2021.114100. Epub 2021 Dec 23.

¹ Nanotechnology Characterization Lab., Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD 21704, USA. Electronic address: marina@mail.nih.gov.
² Nanoscale Science Program, Department of Chemistry, The University of North Carolina at Charlotte, Charlotte, NC 28223, USA.
³ CINBIO, Universidade de Vigo, Immunology Group, Vigo, Spain; Galicia Sur Health Research Institute (IIS-GS), Hospital Alvaro Cunqueiro, Vigo, Spain.

No abstract available

Publication types